Total AS/SpA Patients | AS/SpA Patients Efficacy/failures | AS/SpA Patients Toxicity/Unmet needs | |
Etanercept | 62 | BASDAI < 4 achieved in nearly all patients 3 patients-inefficacy* | 1 patient-cellulitis 6 patients-UTI 1 patient-folliculitis and multiple abscesses |
Infliximab | 140 | BASDAI < 4 achieved in nearly all patients 3 patients-inefficacy* | 3 patients-pulm. TB** 4 patients-UTI 1 patient – pneumonia 1 patient- “Conjunctival tumour” (dysplastic growth) |